Sabinsa probiotic found to reverse depression in IBS patients

636686183222121290brain.jpg

31 Jul 2018 --- Adults with irritable bowel syndrome (IBS) show improvement from co-existing depression when taking the probiotic strain Bacillus coagulans MTCC 5856, Sabinsa’s LactoSpore, versus subjects given a placebo, according to a clinical study published in the journal Food & Nutrition Research. These findings hint at the possibility that LactoSpore may be a new treatment option for major depressive disorder in IBS patients and open new avenues for the probiotic’s use in gut and psychological conditions.

IBS is characterized by the alterations in bowel function or discomfort, abdominal pain or bloating and diarrhea or constipation, with a prevalence estimated between 9 percent and 23 percent in the population across the world. IBS patients are also frequently affected by chronic anxiety, mood disorders and major depression.

This study provides evidence of clinical efficacy of B. coagulans MTCC 5856 in patients experiencing major depression symptoms with IBS and supports the hypothesis that the modification of microbial ecology in human gut by supplementing probiotics may be an alternative strategy to ameliorate or prevent depression. 

The study demonstrates that consumption of probiotic B. coagulans MTCC 5856 may improve gut symptoms and psychological issues, i.e., major depression, sleeplessness and dementia in IBS. This provides a new opportunity not only to help patients suffering from gastrointestinal related disorders but also the patients suffering from extra-intestinal disorders such as major depression, quality of sleep and dementia.

This 90 day randomized, double-blind, placebo-controlled trial involved 40 adults with IBS co-existing with major depressive disorder. Twenty participants took a daily dose of the probiotic B. coagulans MTCC 5856 (2 billion spores per day) and other 20 subjects were on placebo. At 90 days, subjects receiving the probiotic (2 × 109 spores/day) reported a significant change/decrease in their depression clinical symptoms along with a decrease in IBS as compared to subjects receiving placebo. It was also noticed that the subjects in the B. coagulans MTCC 5856 group reported improvement in sleeplessness and to a lesser extent for dementia.

The study reported no clinically significant changes in vital signs, no abnormal lab values (biochemistry and hematology), and also no Serious Adverse Events or Significant Adverse Events associated with the consumption of probiotic B. coagulans MTCC 5856, suggesting its excellent clinical safety in patients suffering from major depression with IBS.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Fasting may improve health and shield against age-related diseases, study finds

17 Jan 2019 --- Fasting intermittently (IF) may reprogram a variety of cellular responses and result in a range of health benefits, according to a US study conducted on mice. Fasting was found to affect circadian clocks in the liver and skeletal muscles, causing them to rewire their metabolism, which may promote health and protect from age-related diseases. The research, published in Cell Reports, opens new pathways of investigation that may lead to the development of nutritional strategies to improve health in humans.

Health & Nutrition News

Microbiome holds potential for treating milk allergy, mice study finds

16 Jan 2019 --- Gut microbes from healthy infant donors transplanted into mice prevented allergic reactions to milk, while gut microbes from infant donors with milk allergies failed to do the same, according to a Chicago University study. Supported by the US National Institutes of Health (NIH) and published in Nature Medicine, the study findings suggest that gut microbes can significantly affect allergic responses to foods.

Health & Nutrition News

A failing strategy? Gestational diabetes risk not lowered through reduced weight gain research finds

15 Jan 2019 --- Conventional ways to prevent gestational diabetes mellitus are ineffective and its appearance possibly depends on each individual’s health, according to a recent Pennington Biomedical study. The results found that moms-to-be who ate healthier and less, and increased their physical activity, developed gestational diabetes at about the same rates as women who didn't follow the same lifestyle. The researchers now believe there may be different types of gestational diabetes that warrant different approaches to treatment and prevention.

Health & Nutrition News

Unhealthy demographic targeting? Bulk of black and Hispanic teens US food TV advertising budget goes on junk options

15 Jan 2019 --- Of the US$1.1 billion spent on advertising to black and Hispanic teens – via Spanish-language and black-targeted TV programming – over 80 percent was channeled to adverts for fast food restaurants and by food and beverage companies marketing unhealthy food. This is according to a report from the Rudd Center for Food Policy & Obesity at the University of Connecticut.

Health & Nutrition News

Size matters: BFN launches portion-focused dietary guide

15 Jan 2019 --- A practical guide to navigating food portion sizes by simply using one’s hands or a spoon has been released by the British Nutrition Foundation (BFN). The guide seeks to help consumers understand which foods to eat, how often and in what quantities, to maintain a healthy weight and lifestyle. It is available in three forms, as a fridge poster with an overview of the recommendations, a booklet which expands on how to put the advice into practice and a digital, downloadable guide, with advice on portion sizes for a variety of foods.

More Articles
URL : http://www.nutritioninsight.com:80/news/sabinsa-probiotic-found-to-reverse-depression-in-ibs-patients.html